VF
ONCS

Virtu Financial’s OncoSec Medical Incorporated ONCS Stock Holding History

Virtu Financial’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,987
Closed -$22K – 2504
2022
Q4 		$22K Buy
12,987
+12,444
+2,292% +$69.7K ﹤0.01% 1257
2022
Q3 		$6K Buy
+543
New +$8.16K ﹤0.01% 1579
2022
Q2 		– Sell
-699
Closed -$18K – 2407
2022
Q1 		$18K Buy
699
+197
+39% +$4.16K ﹤0.01% 1313
2021
Q4 		$11K Sell
502
-642
-56% -$21.7K ﹤0.01% 1575
2021
Q3 		$54K Buy
1,144
+569
+99% +$28.8K ﹤0.01% 1266
2021
Q2 		$36K Buy
+575
New +$52.2K ﹤0.01% 1376
2020
Q4 		– Sell
-462
Closed -$34K – 1996
2020
Q3 		$34K Buy
+462
New +$36K 0.01% 866
2017
Q4 		– Sell
-217
Closed -$46K – 3304
2017
Q3 		$46K Buy
+217
New +$48.4K ﹤0.01% 2241

Other funds holding ONCS

FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial's ONCS Position: Q1 2023 in Review

Virtu Financial sold out of OncoSec Medical Incorporated (ONCS) in Q1 2023, closing a stake of 12,987 shares — an estimated $22K sold.

Virtu Financial first reported a position in ONCS in Q3 2017 and held it in 8 quarters. The position peaked at $54K in Q3 2021. 12 funds tracked by Wall St. Rank hold ONCS as of Q1 2023.

  • Virtu Financial reported no remaining OncoSec Medical Incorporated position as of Q1 2023 after selling out during the quarter.
  • Virtu Financial sold 12,987 OncoSec Medical Incorporated shares in Q1 2023, an estimated $22K.
  • Virtu Financial first reported a position in OncoSec Medical Incorporated in Q3 2017 and held it in 8 quarters.
  • Virtu Financial's OncoSec Medical Incorporated position peaked at $54K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2023.

Based on Virtu Financial's 13F filing for Q1 2023, filed 1 May 2023.